You are here

ofatumumab

Novartis set to take on Roche as FDA clears first at-home, injectable MS drug

Biopharma Dive

Thu, 08/20/20 - 10:52 pm

multiple sclerosis

FDA Delays Ruling on Novartis’ Relapsing Multiple Sclerosis Drug

BioSpace

Wed, 06/3/20 - 11:08 am

relapsing multiple sclerosis

Novartis builds case for MS drug ofatumumab as FDA decision looms

Pharmaforum

Wed, 05/27/20 - 10:22 am

clinical trials

multiple sclerosis

Novartis’ ofatumumab meets primary endpoints in two phase 3 RMS trials

Pharmaceutical Business Review

Mon, 09/2/19 - 12:24 pm

clinical trials

relapsing multiple sclerosis

Novartis takes aim at Roche's star MS drug

Reuters

Fri, 08/30/19 - 10:08 am

multiple sclerosis

Upcoming events – Phase III data for Chiasma and Novartis

EP Vantage

Fri, 05/17/19 - 07:23 pm

clinical trials

multiple sclerosis

GlaxoSmithKline flips an MS project to Novartis for up to $1B

Fierce Biotech

Fri, 08/21/15 - 09:29 am

multiple sclerosis

Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint

The Fly on the Wall

Mon, 05/19/14 - 03:17 pm

large B-cell lymphoma

Genmab announces positive results for sclerosis drug candidate

Reuters

Thu, 10/10/13 - 06:19 pm

multiple sclerosis

GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Yahoo/Globe Newswire

Sat, 10/5/13 - 09:31 am

chronic lymphocytic leukemia

GlaxoSmithKline amends deal with Genmab

Yahoo/AP

Fri, 07/2/10 - 09:41 am